Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.

Abstract

A prospective randomized trial on 312 patients with locally advanced cervical carcinoma (FIGO stages IB-IV) was carried out. The 5-year survival in 90 patients treated with radiotherapy and antitumor polysaccharide sizofiran, an extract from the culture broth of Schizophyllum commune Fries, in combination was significantly (P = 0.045) better than that in 82… (More)

Topics

Cite this paper

@article{Miyazaki1995ActivatedT, title={Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.}, author={Kohji Miyazaki and Hitoshi Mizutani and Hidetaka Katabuchi and Kazuyuki Fukuma and Shigeru Fujisaki and Hiro-oki Okamura}, journal={Gynecologic oncology}, year={1995}, volume={56 3}, pages={412-20} }